Developer docs
API playgroundTry for free, no card

Search company profiles

MITAS Medical

Full company profile

uuid000iaph

Namestring
MITAS Medical
Legal namestring
株式会社 MITAS Medical
Company typeenum
Private
Founded yearint
2017
Descriptiontext

MITAS Medical (株式会社 MITAS Medical) is a Tokyo-based, founder-led medical device and telemedicine company founded in April 2017 by Dr. Naofumi Kita, a practicing ophthalmologist. The company builds an end-to-end teleophthalmology platform branded "Mobile Eye Doctor" that connects medically underserved patients with remote ophthalmologists. Its core hardware, the MS1, is a smartphone-mountable mobile slit-lamp microscope co-developed with Takagi Seiko Corporation; its key design point is forehead-stabilized image capture that lets non-ophthalmologist clinicians take diagnostic-quality eye images and video without the roughly one year of training conventional slit-lamp operation requires. The MS1 is paired with three software components: the Thorrel Android app (patient records, medical interview input, and image capture), the Hodzzy cloud service (specialized ophthalmic data storage and synchronization), and the iYobow web system, where ophthalmologists review uploaded data, customize examination items per project, and generate PDF reports.

The company serves rural and remote-island clinics, non-ophthalmologist general practitioners, and developing-country health systems where ophthalmologists are scarce and concentrated in cities. It operates a B2B/B2G field-sales motion, selling devices and subscription software to hospitals, clinics, municipalities, and government health programs, with deals reached through government tenders, accelerator networks, and direct institutional outreach. Pricing is quote-based and not publicly disclosed; revenue mechanics combine MS1 hardware sales (distributed through the Takagi Seiko partnership and reportedly on market in 80 countries) with recurring software/subscription services. Go-to-market relies heavily on government and development-agency programs — JICA, JETRO, METI/Medical Excellence Japan — that fund pilots and verification studies as a precursor to broader deployment.

Operationally, MITAS has run pilots and projects in Mongolia (20 clinics; a 2021 tele-checkup project targeting 10,000+ residents), Cambodia, Indonesia (a JICA COVID-19 ICT study), Bangladesh (METI verification with SHIP International Hospital), and within Japan (Hiroshima remote islands and a Medical MaaS vehicle integration in Sakai Town with MONET Technologies). The company is privately held with a simple ownership structure; disclosed capital is approximately 100 million yen, and it has taken undisclosed-amount funding from Capital Medica Ventures (2019) and strategic corporate funding from Takagi Seiko (2020). Headcount is 11–50.

Short descriptiontext

MITAS Medical builds a teleophthalmology platform — the MS1 smartphone-mounted slit-lamp device plus app, cloud, and web examination software — that connects non-specialist clinicians in rural, remote, and developing-country settings to remote ophthalmologists, sold B2B to hospitals, clinics, and government health programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTokyo, Japan
HQ citystring
Tokyo
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
smartphone ophthalmic diagnostics, teleophthalmology platform, mobile slit-lamp imaging, remote eye care devices, ophthalmology telemedicine software
Industry4 codes
1Ophthalmology & Vision Telemedicine Platforms
CodeHLALAGALPrimaryYes
2Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment)
CodeHLAHAJAMPrimaryNo
3Mobile Imaging Services
CodeHLAFAKACPrimaryNo
4Second Opinion & Expert Matching Platforms
CodeHLALALACPrimaryNo
NAICS code3 codes
  • Ophthalmic Goods Manufacturing339115
  • Ophthalmic Goods Merchant Wholesalers423460
  • Offices of Physicians6211
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Ophthalmic Goods3851
Product category
Teleophthalmology devices and platforms
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1MS1 Device Sales
TypeHardware Sales
Description

Sale of the MS1 smartphone-connected ophthalmic diagnostic hardware device. Jointly developed with Takagi Seiko Corporation. Currently available in 80 countries.

mitasmedical.com
2Software/Subscription Services
TypeSubscription Recurring
Description

Thorrel app, Hodzzy cloud storage, and iYobow examination system likely operate on a subscription or per-user basis for healthcare institutions. Revenue model details not fully publicly disclosed.

mitasmedical.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
Pricing details1 tier
1Enterprise/B2B pricing for healthcare institutions
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed. Device sold alongside subscription services for healthcare institutions.

mitasmedical.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Mobile Eye Doctor
Description

Tele-medicine service that connects ophthalmologists and people who need ophthalmic care, using MS1 device and dedicated applications.

+4 more records
Core offering1 text field

MITAS Medical develops and sells the MS1, a smartphone-mounted mobile slit-lamp microscope that condenses traditional ophthalmic diagnostic imaging into a smartphone-attached device, enabling clinicians without ophthalmology training to capture diagnostic-quality eye images and videos. The MS1 is paired with the "Mobile Eye Doctor" teleophthalmology platform—Thorrel (patient-data Android app), Hodzzy (cloud storage), and iYobow (web examination system for remote ophthalmologists)—delivered to hospitals, clinics, government health programs, and international development organizations so that specialists can remotely examine patients in rural, remote-island, and underserved areas.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 100+ diagnoses per month in Mongolia pilot with early glaucoma detection cases preventing vision loss
+4 more records
Product overview1 text field

MITAS Medical offers a unified telemedicine platform called Mobile Eye Doctor, comprising four integrated products: MS1 (a smartphone-connected ophthalmic diagnostic device), Thorrel (a smartphone application for patient data management and eye imaging), Hodzzy (a cloud service for data storage and sharing), and iYobow (a web-based examination system for ophthalmologists). These products work together to enable remote eye consultations, allowing clinicians without ophthalmology experience to capture eye images and connect with specialists for diagnosis and treatment recommendations.

Product and service5 records
1MS1 smartphone-connected ophthalmic device
CategoryOphthalmic diagnostic hardware
Description

A mobile slit-lamp microscope condensed into a smartphone-mountable device (jointly developed with Takagi Seiko Corporation) that lets clinicians without ophthalmology training capture diagnostic-quality eye images and videos, with forehead stabilization support that reduces the conventional ~1 year of slit-lamp training to short practice. Available in 80 countries.

2Thorrel mobile application
CategoryMedical imaging mobile software
Description

An Android application installed on smartphones connected to the MS1 device that manages patient information, captures medical interview input, and records eye images/videos linked to patient records for transmission to remote ophthalmologists.

3Hodzzy cloud service
CategoryHealthcare data storage and synchronization
Description

A cloud platform specialized in storing ophthalmic medical data, including eye images and examination data, enabling browser-based data access within organizations and automatic synchronization with the iYobow examination system.

4iYobow web examination system
CategoryClinical examination and reporting software
Description

A web-based service enabling professional ophthalmologists to perform eye examinations based on MS1 image data and medical interview information, with project-customized examination items, automated notifications, and PDF report generation.

5Mobile Eye Doctor teleophthalmology service
CategoryTeleophthalmology service
Description

End-to-end telemedicine service connecting ophthalmologists with patients and general clinicians in areas with limited access to eye care, integrating the MS1 device, Thorrel application, Hodzzy cloud, and iYobow examination system into a three-step remote consultation workflow (data entry via smartphone app, specialist advice, on-screen confirmation).

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierKeyTypeGTM or Marketing PartnerAnnounced on2025-03-26
Description

Selected for JETRO's Japan Tech Africa Challenge (April 2024) and organizing HEALTH DESIGN exhibition at Osaka-Kansai Expo (June 2025). JETRO provides international market development support, exhibition platforms, and trade organization credibility.

2JICA DXLab
Strategic tierSupportingTypeGTM or Marketing PartnerAnnounced on2024-04-25
Description

Published CEO interview on JICA's digital transformation platform, providing marketing visibility and credibility for international development work.

mitasmedical.com
Strategic tierKeyTypeStrategic or Co-development PartnerAnnounced on2023-03-23
Description

Developed 'Multi-Task Vehicles' for Medical MaaS program in Sakai Town, Ibaraki Prefecture. MITAS Medical's teleophthalmology service was integrated into these vehicles for mobile eye care delivery to residents.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2020-10-11
Description

Joint development partner for MS1 smartphone-connected ophthalmic device. Takagi Seiko provided manufacturing expertise and production facilities while MITAS provided software and teleophthalmology platform. Takagi Seiko also provided funding/investment to MITAS Medical. MS1 devices are now sold in 80 countries through this partnership.

5SHIP International Hospital (Bangladesh)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Local medical institution partner in Bangladesh for Healthcare Industry International Promotion Project (METI FY2022). Cooperated during August 2022 visit for free health camps and provided access for MS1 system demonstration to local residents.

mitasmedical.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic medical partner in Mongolia collaborating since 2019 for tele-examination system implementation. Assisted with placing MS1 devices in 20 clinics in western province and connecting them with city ophthalmologists.

7Mongolia Ministry of Health
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Government health ministry partner providing support and approvals for tele-examination pilot projects in Mongolia, enabling deployment of MS1 system across clinics.

mitasmedical.com
8Hiroshima Sandbox
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Selected for D-EGGS PROJECT acceleration program. Hiroshima Sandbox provided funding (up to 13 million yen) and full prefecture as demonstration field for teleconsultation service implementation connecting remote island clinics with mainland ophthalmologists.

mitasmedical.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multiple partnerships: (1) SDGs Business Support Project 2020 for Cambodia survey, (2) PoC partner for COVID-19 ICT countermeasures research with Indonesia demo, (3) DXLab interview publication. JICA provides credibility and funding for international healthcare projects.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Implementing association for METI Healthcare Industry International Promotion Project. Provided support for MITAS's Bangladesh verification study project under this subsidized program.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Listed as partner company on MITAS Medical website, suggesting collaboration for teleophthalmology service deployment.

Strategic tierSupportingTypeGTM or Marketing Partner
Description

Selected for Plug and Play Japan Acceleration Program Summer/Fall 2020 Batch (Hardtech & Health). Provided network access and business development support through global accelerator program.

Strategic tierSupportingTypeGTM or Marketing Partner
Description

Selected for AI.Accelerator program. Provided AI startup acceleration support and network access through DIP Corporation's program.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-based social enterprise building smartphone-based eye screening tools (Peek Acuity, Peek Retina) for use by non-specialists in low-resource settings. Closely comparable to MITAS in mission (preventable blindness) and smartphone-ophthalmology approach.

TypeBroad incumbent
Description

Established Japanese manufacturer of ophthalmic and optometric equipment including slit lamps and fundus cameras. Competes in the same clinical workflow (slit-lamp examination) that MITAS's MS1 device targets to disrupt.

TypeBroad incumbent
Description

Swiss ophthalmic equipment manufacturer with a long-standing slit-lamp product line. Comparable as a traditional slit-lamp incumbent whose core product MITAS's MS1 is positioned to substitute in low-resource settings.

TypeDirect peer
Description

India-based company producing smartphone-based ophthalmic imaging devices (e.g., Fundus on Phone, 3nethra) used for screening and teleophthalmology. Comparable on hardware-software bundle and emerging-market teleophthalmology positioning.

TypeBroad incumbent
Description

Japanese global incumbent in ophthalmic and optometric equipment (slit lamps, fundus cameras, OCT). Comparable as a Japan-headquartered ophthalmic device manufacturer, but operates at vastly larger scale and a much broader product portfolio than MITAS's MS1.

TypeDirect peer
Description

Brazil-based maker of Eyer — a portable, smartphone-connected retinal imaging device used by general clinicians and ophthalmologists for screening. Comparable on portable smartphone-ophthalmology imaging and emerging-market distribution.

TypeBroad incumbent
Description

Germany-based ophthalmic imaging specialist (OCT, fundus imaging, perimetry). Comparable as an established ophthalmic diagnostics vendor, though positioned in the high-end clinical segment rather than MITAS's smartphone-portable niche.

TypeDirect peer
Description

India-based developer of portable, low-cost ophthalmic screening devices (3nethra series) deployed across India, Africa, and Southeast Asia. Comparable on portable teleophthalmology hardware for underserved populations.

TypeDirect peer
Description

Italy/US-based developer of smartphone retinal imaging adapters and screening platforms. Directly comparable product category (smartphone-attached ophthalmic hardware + tele-screening workflow) and customer base (non-ophthalmologists).

TypeDirect peer
Description

New Zealand-based startup producing smartphone ophthalmoscope and retinal imaging adapters for teleophthalmology. Comparable on smartphone-attached ophthalmic hardware targeting non-specialist users.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MITAS Medical

Teleophthalmology devices and platformsmitasmedical.com

MITAS Medical builds a teleophthalmology platform — the MS1 smartphone-mounted slit-lamp device plus app, cloud, and web examination software — that connects non-specialist clinicians in rural, remote, and developing-country settings to remote ophthalmologists, sold B2B to hospitals, clinics, and government health programs.

What MITAS Medical does

MITAS Medical (株式会社 MITAS Medical) is a Tokyo-based, founder-led medical device and telemedicine company founded in April 2017 by Dr. Naofumi Kita, a practicing ophthalmologist. The company builds an end-to-end teleophthalmology platform branded "Mobile Eye Doctor" that connects medically underserved patients with remote ophthalmologists. Its core hardware, the MS1, is a smartphone-mountable mobile slit-lamp microscope co-developed with Takagi Seiko Corporation; its key design point is forehead-stabilized image capture that lets non-ophthalmologist clinicians take diagnostic-quality eye images and video without the roughly one year of training conventional slit-lamp operation requires. The MS1 is paired with three software components: the Thorrel Android app (patient records, medical interview input, and image capture), the Hodzzy cloud service (specialized ophthalmic data storage and synchronization), and the iYobow web system, where ophthalmologists review uploaded data, customize examination items per project, and generate PDF reports.

The company serves rural and remote-island clinics, non-ophthalmologist general practitioners, and developing-country health systems where ophthalmologists are scarce and concentrated in cities. It operates a B2B/B2G field-sales motion, selling devices and subscription software to hospitals, clinics, municipalities, and government health programs, with deals reached through government tenders, accelerator networks, and direct institutional outreach. Pricing is quote-based and not publicly disclosed; revenue mechanics combine MS1 hardware sales (distributed through the Takagi Seiko partnership and reportedly on market in 80 countries) with recurring software/subscription services. Go-to-market relies heavily on government and development-agency programs — JICA, JETRO, METI/Medical Excellence Japan — that fund pilots and verification studies as a precursor to broader deployment.

Operationally, MITAS has run pilots and projects in Mongolia (20 clinics; a 2021 tele-checkup project targeting 10,000+ residents), Cambodia, Indonesia (a JICA COVID-19 ICT study), Bangladesh (METI verification with SHIP International Hospital), and within Japan (Hiroshima remote islands and a Medical MaaS vehicle integration in Sakai Town with MONET Technologies). The company is privately held with a simple ownership structure; disclosed capital is approximately 100 million yen, and it has taken undisclosed-amount funding from Capital Medica Ventures (2019) and strategic corporate funding from Takagi Seiko (2020). Headcount is 11–50.

MITAS Medical firmographics

Firmographics
Name
MITAS Medical
Legal name
株式会社 MITAS Medical
Website
https://mitasmedical.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
MITAS Medical builds a teleophthalmology platform — the MS1 smartphone-mounted slit-lamp device plus app, cloud, and web examination software — that connects non-specialist clinicians in rural, remote, and developing-country settings to remote ophthalmologists, sold B2B to hospitals, clinics, and government health programs.
Ownership category
akta.pro rank

MITAS Medical industry classification

Industry
Product category
Teleophthalmology devices and platforms
NAICS
Ophthalmic Goods Manufacturing (339115), Ophthalmic Goods Merchant Wholesalers (423460), Offices of Physicians (6211)
SIC
Surgical & Medical Instruments & Apparatus (3841), Ophthalmic Goods (3851)
akta.pro primary industry
Ophthalmology & Vision Telemedicine Platforms (HLALAGAL)
akta.pro secondary industries
Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment) (HLAHAJAM), Mobile Imaging Services (HLAFAKAC), Second Opinion & Expert Matching Platforms (HLALALAC)

Keywords

  • Smartphone ophthalmic diagnostics
  • Teleophthalmology platform
  • Mobile slit-lamp imaging
  • Remote eye care devices
  • Ophthalmology telemedicine software

Where MITAS Medical is headquartered

Location

Headquarters

HQ city
Tokyo
HQ country
Japan
HQ region
Asia

Offices1 record

Markets served

MITAS Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. MS1 Device Sales: Sale of the MS1 smartphone-connected ophthalmic diagnostic hardware device. Jointly developed with Takagi Seiko Corporation. Currently available in 80 countries.
  2. Software/Subscription Services: Thorrel app, Hodzzy cloud storage, and iYobow examination system likely operate on a subscription or per-user basis for healthcare institutions. Revenue model details not fully publicly disclosed.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise/B2B pricing for healthcare institutions

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

MITAS Medical product offering

Product offering

Core offering

MITAS Medical develops and sells the MS1, a smartphone-mounted mobile slit-lamp microscope that condenses traditional ophthalmic diagnostic imaging into a smartphone-attached device, enabling clinicians without ophthalmology training to capture diagnostic-quality eye images and videos. The MS1 is paired with the "Mobile Eye Doctor" teleophthalmology platform—Thorrel (patient-data Android app), Hodzzy (cloud storage), and iYobow (web examination system for remote ophthalmologists)—delivered to hospitals, clinics, government health programs, and international development organizations so that specialists can remotely examine patients in rural, remote-island, and underserved areas.

Product overview

MITAS Medical offers a unified telemedicine platform called Mobile Eye Doctor, comprising four integrated products: MS1 (a smartphone-connected ophthalmic diagnostic device), Thorrel (a smartphone application for patient data management and eye imaging), Hodzzy (a cloud service for data storage and sharing), and iYobow (a web-based examination system for ophthalmologists). These products work together to enable remote eye consultations, allowing clinicians without ophthalmology experience to capture eye images and connect with specialists for diagnosis and treatment recommendations.

Differentiator

Problem solved

Functional benefit

Brands

  • Mobile Eye Doctor: Tele-medicine service that connects ophthalmologists and people who need ophthalmic care, using MS1 device and dedicated applications.
  • MS1
  • Thorrel
  • Hodzzy
  • iYobow

Products and services

  • MS1 smartphone-connected ophthalmic device A mobile slit-lamp microscope condensed into a smartphone-mountable device (jointly developed with Takagi Seiko Corporation) that lets clinicians without ophthalmology training capture diagnostic-quality eye images and videos, with forehead stabilization support that reduces the conventional ~1 year of slit-lamp training to short practice. Available in 80 countries.
  • Thorrel mobile application An Android application installed on smartphones connected to the MS1 device that manages patient information, captures medical interview input, and records eye images/videos linked to patient records for transmission to remote ophthalmologists.
  • Hodzzy cloud service A cloud platform specialized in storing ophthalmic medical data, including eye images and examination data, enabling browser-based data access within organizations and automatic synchronization with the iYobow examination system.
  • iYobow web examination system A web-based service enabling professional ophthalmologists to perform eye examinations based on MS1 image data and medical interview information, with project-customized examination items, automated notifications, and PDF report generation.
  • Mobile Eye Doctor teleophthalmology service End-to-end telemedicine service connecting ophthalmologists with patients and general clinicians in areas with limited access to eye care, integrating the MS1 device, Thorrel application, Hodzzy cloud, and iYobow examination system into a three-step remote consultation workflow (data entry via smartphone app, specialist advice, on-screen confirmation).

Quantifiable outcome

  • 100+ diagnoses per month in Mongolia pilot with early glaucoma detection cases preventing vision loss
  • +4 more outcomes

Companies that use MITAS Medical

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

MITAS Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

MITAS Medical partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered key, supporting and core.

  • JETRO (Japan External Trade Organization)keyGTM or Marketing Partner · 26 March 2025Selected for JETRO's Japan Tech Africa Challenge (April 2024) and organizing HEALTH DESIGN exhibition at Osaka-Kansai Expo (June 2025). JETRO provides international market development support, exhibition platforms, and trade organization credibility.
  • JICA DXLabsupportingGTM or Marketing Partner · 25 April 2024Published CEO interview on JICA's digital transformation platform, providing marketing visibility and credibility for international development work.
  • MONET Technologies Co., Ltd.keyStrategic or Co-development Partner · 23 March 2023Developed 'Multi-Task Vehicles' for Medical MaaS program in Sakai Town, Ibaraki Prefecture. MITAS Medical's teleophthalmology service was integrated into these vehicles for mobile eye care delivery to residents.
  • Takagi Seiko Co., Ltd. (株式会社タカギセイコー)coreTechnology or Integration · 11 October 2020Joint development partner for MS1 smartphone-connected ophthalmic device. Takagi Seiko provided manufacturing expertise and production facilities while MITAS provided software and teleophthalmology platform. Takagi Seiko also provided funding/investment to MITAS Medical. MS1 devices are now sold in 80 countries through this partnership.
  • SHIP International Hospital (Bangladesh)coreStrategic or Co-development PartnerLocal medical institution partner in Bangladesh for Healthcare Industry International Promotion Project (METI FY2022). Cooperated during August 2022 visit for free health camps and provided access for MS1 system demonstration to local residents.
  • Mongolian National University of Medical SciencescoreStrategic or Co-development PartnerAcademic medical partner in Mongolia collaborating since 2019 for tele-examination system implementation. Assisted with placing MS1 devices in 20 clinics in western province and connecting them with city ophthalmologists.
  • Mongolia Ministry of HealthcoreStrategic or Co-development PartnerGovernment health ministry partner providing support and approvals for tele-examination pilot projects in Mongolia, enabling deployment of MS1 system across clinics.
  • Hiroshima SandboxcoreStrategic or Co-development PartnerSelected for D-EGGS PROJECT acceleration program. Hiroshima Sandbox provided funding (up to 13 million yen) and full prefecture as demonstration field for teleconsultation service implementation connecting remote island clinics with mainland ophthalmologists.
  • JICA (Japan International Cooperation Agency)coreStrategic or Co-development PartnerMultiple partnerships: (1) SDGs Business Support Project 2020 for Cambodia survey, (2) PoC partner for COVID-19 ICT countermeasures research with Indonesia demo, (3) DXLab interview publication. JICA provides credibility and funding for international healthcare projects.
  • Medical Excellence JAPANcoreStrategic or Co-development PartnerImplementing association for METI Healthcare Industry International Promotion Project. Provided support for MITAS's Bangladesh verification study project under this subsidized program.
  • Sunrise Japan HospitalsupportingStrategic or Co-development PartnerListed as partner company on MITAS Medical website, suggesting collaboration for teleophthalmology service deployment.
  • Plug and Play JapansupportingGTM or Marketing PartnerSelected for Plug and Play Japan Acceleration Program Summer/Fall 2020 Batch (Hardtech & Health). Provided network access and business development support through global accelerator program.
  • DIP CorporationsupportingGTM or Marketing PartnerSelected for AI.Accelerator program. Provided AI startup acceleration support and network access through DIP Corporation's program.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

MITAS Medical competitors and assessment

Company assessment

Direct peers

  • Peek Vision: UK-based social enterprise building smartphone-based eye screening tools (Peek Acuity, Peek Retina) for use by non-specialists in low-resource settings. Closely comparable to MITAS in mission (preventable blindness) and smartphone-ophthalmology approach.
  • Remidio Innovative Solutions: India-based company producing smartphone-based ophthalmic imaging devices (e.g., Fundus on Phone, 3nethra) used for screening and teleophthalmology. Comparable on hardware-software bundle and emerging-market teleophthalmology positioning.
  • Phelcom Technologies: Brazil-based maker of Eyer — a portable, smartphone-connected retinal imaging device used by general clinicians and ophthalmologists for screening. Comparable on portable smartphone-ophthalmology imaging and emerging-market distribution.
  • Forus Health: India-based developer of portable, low-cost ophthalmic screening devices (3nethra series) deployed across India, Africa, and Southeast Asia. Comparable on portable teleophthalmology hardware for underserved populations.
  • D-EYE (iHealthScreen): Italy/US-based developer of smartphone retinal imaging adapters and screening platforms. Directly comparable product category (smartphone-attached ophthalmic hardware + tele-screening workflow) and customer base (non-ophthalmologists).
  • oDocs Eye Care: New Zealand-based startup producing smartphone ophthalmoscope and retinal imaging adapters for teleophthalmology. Comparable on smartphone-attached ophthalmic hardware targeting non-specialist users.

Broad incumbents

  • Nidek Co., Ltd. Established Japanese manufacturer of ophthalmic and optometric equipment including slit lamps and fundus cameras. Competes in the same clinical workflow (slit-lamp examination) that MITAS's MS1 device targets to disrupt.
  • Haag-Streit Group: Swiss ophthalmic equipment manufacturer with a long-standing slit-lamp product line. Comparable as a traditional slit-lamp incumbent whose core product MITAS's MS1 is positioned to substitute in low-resource settings.
  • Topcon Corporation: Japanese global incumbent in ophthalmic and optometric equipment (slit lamps, fundus cameras, OCT). Comparable as a Japan-headquartered ophthalmic device manufacturer, but operates at vastly larger scale and a much broader product portfolio than MITAS's MS1.
  • Heidelberg Engineering: Germany-based ophthalmic imaging specialist (OCT, fundus imaging, perimetry). Comparable as an established ophthalmic diagnostics vendor, though positioned in the high-end clinical segment rather than MITAS's smartphone-portable niche.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

MITAS Medical social profiles

Digital presence

MITAS Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MITAS Medical leadership team

Management profile

Number of profiles

Profiles2 records

MITAS Medical funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MITAS Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MITAS Medical

What does MITAS Medical do?

MITAS Medical develops and sells the MS1, a smartphone-mounted mobile slit-lamp microscope that condenses traditional ophthalmic diagnostic imaging into a smartphone-attached device, enabling clinicians without ophthalmology training to capture diagnostic-quality eye images and videos. The MS1 is paired with the "Mobile Eye Doctor" teleophthalmology platform—Thorrel (patient-data Android app), Hodzzy (cloud storage), and iYobow (web examination system for remote ophthalmologists)—delivered to hospitals, clinics, government health programs, and international development organizations so that specialists can remotely examine patients in rural, remote-island, and underserved areas.

Is MITAS Medical a public or private company?

MITAS Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was MITAS Medical founded?

MITAS Medical was founded in 2017. It employs 11 to 50 people.

Where is MITAS Medical based?

MITAS Medical is headquartered in Tokyo, Japan, in the Asia region.

How does MITAS Medical make money?

Two revenue lines are on record. MS1 Device Sales are the primary driver. The others are software/Subscription Services.

Who are MITAS Medical's main competitors?

Direct peers on record are Peek Vision, Remidio Innovative Solutions, Phelcom Technologies, Forus Health, D-EYE (iHealthScreen) and oDocs Eye Care. Broad incumbents are Nidek Co., Ltd., Haag-Streit Group, Topcon Corporation and Heidelberg Engineering.

Does MITAS Medical have an API?

No public API is recorded for MITAS Medical.

What industry is MITAS Medical in?

MITAS Medical's product category is Teleophthalmology devices and platforms. Its primary akta.pro industry code is HLALAGAL, Ophthalmology & Vision Telemedicine Platforms, with a secondary code of HLAHAJAM, Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment). Its NAICS code is 339115 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales